Rate My Professor Lulu Jiang

Dr. Jiang’s research centers on the pathophysiology of neurodegenerative diseases, particularly Alzheimer’s disease and tauopathies, with emphasis on epitranscriptomic regulation via RNA modifications like m6A, neuron-glia interactions, neuroimmunological mechanisms, prion-like tau propagation, and iPSC-derived 3D human brain organoid models for precision medicine and therapeutic development. Her seminal publications include “Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy” (Molecular Cell, 2021), “Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress” (Science Advances, 2023), “TIA1 regulates the generation and response to toxic tau oligomers” (Acta Neuropathologica, 2019), and “Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model” (Nature Communications, 2022). Jiang has secured major funding, including a $3.6 million R01 grant from the National Institute on Aging in 2024 for investigating epitranscriptomic mechanisms in Alzheimer’s disease pathogenesis, and over $200,000 from the Cure Alzheimer’s Foundation in 2025, in collaboration with Yimin Zou, Ph.D., to study tau-mediated synapse loss. Her prior honors encompass Alzheimer’s Association travel awards, Tau2020 Fellowship, and multiple outstanding dissertation and scholarship awards from Shandong University and Chinese ministries.